Tatva Chintan Pharma Chem Limited – Investor Presentation Summary

Key Operational Highlights

  • Existing combined installed reactor capacity of 791KL & 39 Assembly Lines as on 31 March 2026 across Ankleshwar and Dahej SEZ plants.
  • R&D team of 56 employees including 26 senior highly qualified scientists as of 31st March 2026.
  • Customer Base spanning over 25 Countries including USA, UK, China, Germany, Japan and South Africa.
  • Credit Rating of CRISIL BBB+/ Stable & A2.

Key drivers of operational performance: Expansion of product categories, focus on green chemistry processes (electrolysis, continuous flow chemistry), and overseas market penetration.

Segment-wise Performance

  • Phase Transfer Catalyst (PTC): Revenue of ₹428 Mn in Q1FY27 (26% of total revenue); FY26 revenue ₹1,173 Mn (23% of revenue). Manufacturing since 1996.
  • Structure Directing Agents (SDA): Revenue of ₹578 Mn in Q1FY27 (35% of total revenue); FY26 revenue ₹2,045 Mn (41% of revenue). Manufacturing since 2015. Second largest manufacturer globally.
  • Electrolyte Salts & Solutions (ESS): Revenue of ₹63 Mn in Q1FY27 (4% of total revenue); FY26 revenue ₹165 Mn (3% of revenue). Manufacturing since 2016. Largest producer in India.
  • Pharmaceuticals and Agrochemicals Intermediates (PASC): Revenue of ₹584 Mn in Q1FY27 (34% of total revenue); FY26 revenue ₹1,623 Mn (32% of revenue). Manufacturing since 2016. Largest producer of Glymes in India.

Explanation of significant changes in segment performance: Growth driven by expanded market share in SDA and PTC categories, with increased demand for green chemistry solutions.

Financial Highlights

Revenue: Rs. 1,671 Mn (Q1FY27)

EBITDA: Rs. 323 Mn (Q1FY27)

PAT: Rs. 160 Mn (Q1FY27)

EBITDA Margin: 19% (Q1FY27)

PAT Margin: Not explicitly stated

YoY/QoQ comparison: Revenue up 43% YoY (from ₹1,169 Mn in Q1FY26) and 25% QoQ (from ₹1,341 Mn in Q4FY26). PAT up 140% YoY (from ₹67 Mn) and 55% QoQ (from ₹103 Mn). EBITDA up 86% YoY (from ₹173 Mn) and 15% QoQ (from ₹281 Mn).

Drivers of financial performance: Higher revenue growth across product categories, operational efficiencies, and margin expansion.

Comparison to market estimates: Not specified

Key Risks: Not explicitly disclosed

Geographical Revenue Split

Domestic vs Export/Regional Revenue: Exports constitute 75% of revenue in FY25 (specific Q1FY27 split not provided).

Regional Breakdown: Not specified beyond export percentage.

Balance Sheet Snapshot

Net Debt/Equity: Not explicitly calculated

Reserves: Part of Other Equity: ₹7,583.67 Mn (31-Mar-26)

Current Assets: ₹3,527.04 Mn (31-Mar-26)

Current Liabilities: ₹2,163.27 Mn (31-Mar-26)

Working Capital/Leverage Metrics: Not explicitly provided

Financial Health Insights: Tangible net worth increased to ₹7,817.59 Mn (31-Mar-26) from ₹7,388.24 Mn (31-Mar-25).

Capex & Cash Flow Health

Capital Expenditure: Not specified for current period

Free Cash Flow: Not provided

Operating Cash Flow: Not provided

Net Debt Movement: Long-term borrowings increased to ₹50.10 Mn (31-Mar-26) from ₹0 Mn (31-Mar-25).

Investment Rationale: Capacity expansion and technology upgrades across manufacturing facilities.

Strategic & R&D Initiatives

Investments in Innovation: R&D focus on electrolysis, continuous flow chemistry, and green chemistry processes. R&D capital and revenue expenditure shown but values not specified in presentation.

Expected impact on growth: Not quantified

Strategic Rationale: Expanding into high-growth markets, reducing operational costs through green chemistry.

Industry Trends & Business Environment

Macro/Industry Trends: India's share in global chemical industry at 3% (2025 data), with opportunity from China+1 policy and stricter environmental regulations. Shift towards sustainable product development.

Impact on Company: Beneficiary of supply chain diversification away from China and growing demand for green chemicals.

Management Commentary & Growth Outlook

Strategic Outlook: Not explicitly quoted

FY Guidance: Not provided

Market Share Targets: Not specified

Risks and Opportunities: Not highlighted in presentation

Additional Headings

ESG Updates: Ankleshwar facility converted to 'zero liquid effluent discharge' in January 2020. Use of PNG as boiler fuel. Sustainability performance above industry average per EcoVadis and TfS assessments.

Digital Transformation: Not specified